"10.1371_journal.pone.0148980","plos one","2016-02-16T00:00:00Z","Liv-Marie Eike; Brynjar Mauseth; Ketil André Camilio; Øystein Rekdal; Baldur Sveinbjørnsson","Department of Molecular Inflammation Research, Institute of Medical Biology, Faculty of Health, University of Tromsø, N-9037, Tromsø, Norway; Lytix Biopharma, Gaustad Alléen, Oslo, Norway; Childhood Cancer Research Unit, Department of Women’s and Children’s Health, Karolinska Institute, Stockholm, Sweden","Conceived and designed the experiments: LE BM KC ØR BS. Performed the experiments: LE BM KC BS. Analyzed the data: LE BM KC ØR BS. Wrote the paper: LE BM KC ØR BS.","The study received funding from Lytix Biopharma. Øystein Rekdal is employed by Lytix Biopharma AS. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2016","02","Liv-Marie Eike","LME",5,TRUE,5,4,5,5,TRUE,TRUE,FALSE,0,NA,FALSE
